This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB08057/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB08057/identifier/pubchem-compound/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08057/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08057/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08057
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB08057 n11:DB08057
dcterms:title
N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine
adms:identifier
n6:46937119 n7:99444528 n10:DB08057 n12:KSM
n3:IUPAC-Name
n4:271B59D0-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B59D6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B59D5-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B59D2-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B59D3-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B59D4-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B59CE-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B59CC-363D-11E5-9242-09173F13E4C5 n4:271B59CF-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B59CD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B59DC-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B59DD-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B59D7-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B59D8-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B59DA-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B59D9-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B59DB-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B59E2-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B59E4-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B59E5-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B59E1-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B59E0-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B59E3-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B59D1-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B59DE-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B59DF-363D-11E5-9242-09173F13E4C5